Cross Country Healthcare (CCRN) Tops Q1 EPS by 9c; misses on guidance

Cross Country Healthcare (NASDAQ: CCRN) reported Q1 EPS of $0.84, $0.09 better than the analyst estimate of $0.75. Revenue for the quarter came in at $622.71 million versus the consensus estimate of $595.03 million.

GUIDANCE:

Cross Country Healthcare sees Q2 2023 EPS of $0.55-$0.65, versus the consensus of $0.75. Cross Country Healthcare sees Q2 2023 revenue of $530-540 million, versus the consensus of $553.9 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
• KeyBanc lowers Nike rating to Sector Weight on near-term uncertainty
• H.B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook